WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of POZEN INC (POZN)

Name POZEN INC
Year low 2.15
Year High 8.12
Symbol POZN
Last trade 6.55
Percentage change -1.36
Volume 53,054
Media Volume (3m) 580,116
PE Ratio 5.07
EPS 1.31
Market Cap 195
Media fatt 105
Trend fatt trend fatt graph for POZEN INC
Media net income 61
Trend net income trend net income for POZEN INC
P / E P / E graph for POZEN INC - 16 points 16
EPS EPS graph for POZEN INC - 14 points 14
MARKET CAP / TOTAL REVENUE market  cap  /  total  revenue  graph for POZEN INC - 5 points 5
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for POZEN INC - 0 points 0
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for POZEN INC - 0 points 0
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for POZEN INC - 12 points 12
NET INCOME / MARKET CAP NET  INCOME  /  MARKET  CAP graph for POZEN INC - 9 points 9
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for POZEN INC - 0 points 0
NET INC1/NET INC3 net inc1/net inc3 graph for POZEN INC - 3 points 3
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for POZEN INC - 8 points 8
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for POZEN INC - 9 points 9
. . graph for POZEN INC - 0 points 0
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for POZEN INC - 2 points 2
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for POZEN INC - 2 points 2
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for POZEN INC - 1 points 1
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for POZEN INC - 3 points 3
. . graph for POZEN INC - 0 points 0
SELL HOLD BUY SELL           HOLD          BUY graph for POZEN INC - 0 points 0
SINTESE 84

GRAPHS

max price logarithm graph for POZEN INC based on no conditions max volume linear graph for POZEN INC based on no conditions

News

POZEN to Present at the Jefferies 2012 Global Healthcare Conference (May 22 - reuters) 6 Healthcare Stocks Undervalued By Earnings Growth, The Graham Number (May 20 - reuters) PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole (40 mg) (May 19 - reuters) Pozen Shares On The Rebound Since European Migraine Licensing Deal (May 14 - reuters) POZEN Announces Licensing Deal with Desitin Arzneimittel GMBH for MT 400 Migraine Treatment in 29 European Countries (May 08 - reuters) UPDATE 1-Pozen posts wider loss, to review forecast (May 01 - reuters) POZEN Reports PA32540 / PA8140 Updates and First Quarter 2012 Financial Results (May 01 - reuters) 9 Undervalued Healthcare Stocks Being Snapped Up By Hedge Funds (Apr 29 - reuters) FDA Throws Pozen A Curveball (Apr 27 - reuters) 21 Outperforming Hedge Fund Stock Picks Reporting Earnings Next Week (Apr 26 - reuters) Top 10 Stocks With Increasing Sales And Profit Margins (Apr 24 - reuters) 10 Rallying High-Cash Stocks Being Bought Up By Hedge Funds (Apr 20 - reuters) POZEN Announces May 1, 2012 Webcast of First Quarter 2012 Results (Apr 18 - reuters) MAP Pharma: Still Potentially A Good Short Sell (Apr 17 - reuters) Pozen's CEO Responds to Questions About His Firm's Latest Developments and Positive Key Clinical Trial Results (Mar 26 - reuters) New drug promises relief from aspirin heartburn (Mar 22 - reuters) 8 Stocks Under $10 Making Big Moves (Mar 22 - reuters) New drug promises relief from aspirin heartburn (Mar 22 - reuters) POZEN Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of PA32540 (Mar 22 - reuters) Pozen's Final Results On Ulcer Safe Aspirin Can Send Shares Soaring (Mar 20 - reuters) 4 Extremely Undervalued Stocks To Add To Your Portfolio (Mar 19 - reuters) POZEN to Present at the 24th Annual ROTH Conference (Mar 01 - reuters) POZEN Reports Fourth Quarter & Year End 2011 Results (Feb 28 - reuters) POZEN Announces February 28, 2012 Webcast of Fourth Quarter & Year End 2011 Results (Feb 14 - reuters) POZEN`s Digital Advisory Board to Speak at Annual ePharma Summit (Feb 02 - reuters) Preventive Aspirin Use Less Than Optimal in Stroke Survivors Despite Clinical Guidelines (Feb 02 - reuters) Q&A Exclusive: POZEN's Team Confident About Building Shareholder Value in 2012 and Beyond (Jan 11 - reuters) 6 Great Stocks To Buy Now For Profits In 2012 (Dec 30 - reuters) Twelve Biotech Picks For 2012 (Dec 23 - reuters) Pozen Has No Debt And Plenty Of Resources For 2012 NDA Filing (Nov 29 - reuters) Pozen Deal Unlocks Value (Nov 29 - reuters) UPDATE 1-Pozen now forecasts profit for 2011 (Nov 28 - reuters) 5 of Last Week's Biggest Winners (Nov 28 - reuters) POZEN Monetizes Its Treximet Royalty Stream for $75 Million (Nov 28 - reuters) POZEN Reports Top-Line Data from Long-Term Safety Study of PA32540 (Nov 24 - reuters) POZEN Announces November 3, 2011 Webcast of Third Quarter 2011 Results (Nov 24 - reuters) POZEN Reports Third Quarter 2011 Results (Nov 24 - reuters) POZEN To Participate in the Brean Murray Carret & Co. 2011 Life Sciences Summit (Nov 24 - reuters) Pozen to Present at the Lazard Capital Markets` 8th Annual Healthcare Conference (Nov 24 - reuters) Positive Results from POZEN Phase 1 Study ("Co-Rx") Presented At AHA (Nov 24 - reuters) POZEN to Present at the Piper Jaffray 23rd Annual Healthcare Conference (Nov 24 - reuters) REFILE-UPDATE 1-Pozen sells migraine drug's U.S. rights to Canada fund (Nov 24 - reuters) UPDATE 1-Pozen gives 2011 outlook below Street (Oct 04 - reuters) POZEN Provides Patent Litigation and Financial Guidance Update (Oct 04 - reuters) POZEN Announces Engaging Keelin Reeds Partners LLC to Assist With PA32540 Strategic Partner Search (Oct 03 - reuters) POZEN Announces October 4, 2011 Mid-Quarter Update and Financial Guidance Webcast (Sep 27 - reuters) POZEN To Present at the 2011 UBS Global Life Sciences Conference (Sep 08 - businesswire) POZEN To Present at the 2011 UBS Global Life Sciences Conference (Sep 08 - reuters) POZEN to Present at the 2011 Stifel Nicolaus Healthcare Conference (Aug 24 - businesswire) POZEN to Present at the 2011 Stifel Nicolaus Healthcare Conference (Aug 24 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY